Logo image of ALB

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

USA - NYSE:ALB - US0126531013 - Common Stock

80.16 USD
-0.78 (-0.96%)
Last: 9/17/2025, 8:22:40 PM
80.15 USD
-0.01 (-0.01%)
After Hours: 9/17/2025, 8:22:40 PM
Fundamental Rating

3

Taking everything into account, ALB scores 3 out of 10 in our fundamental rating. ALB was compared to 83 industry peers in the Chemicals industry. ALB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ALB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALB had negative earnings in the past year.
ALB had a positive operating cash flow in the past year.
ALB had positive earnings in 4 of the past 5 years.
In the past 5 years ALB always reported a positive cash flow from operatings.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of -6.34%, ALB is doing worse than 72.29% of the companies in the same industry.
With a Return On Equity value of -10.70%, ALB is not doing good in the industry: 67.47% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

ALB has a Gross Margin of 7.76%. This is amonst the worse of the industry: ALB underperforms 85.54% of its industry peers.
In the last couple of years the Gross Margin of ALB has declined.
ALB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALB remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALB has more shares outstanding
ALB has a better debt/assets ratio than last year.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ALB has an Altman-Z score of 1.67. This is a bad value and indicates that ALB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.67, ALB is in line with its industry, outperforming 40.96% of the companies in the same industry.
ALB has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
ALB has a better Debt to Equity ratio (0.31) than 75.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.67
ROIC/WACCN/A
WACC8.36%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

ALB has a Current Ratio of 2.31. This indicates that ALB is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.31, ALB is doing good in the industry, outperforming 62.65% of the companies in the same industry.
A Quick Ratio of 1.47 indicates that ALB should not have too much problems paying its short term obligations.
ALB's Quick ratio of 1.47 is fine compared to the rest of the industry. ALB outperforms 65.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.47
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALB have decreased strongly by -155.42% in the last year.
Looking at the last year, ALB shows a very negative growth in Revenue. The Revenue has decreased by -33.05% in the last year.
ALB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.42% yearly.
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%

3.2 Future

Based on estimates for the next years, ALB will show a very strong growth in Earnings Per Share. The EPS will grow by 63.36% on average per year.
The Revenue is expected to grow by 11.24% on average over the next years. This is quite good.
EPS Next Y29.4%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
EPS Next 5Y63.36%
Revenue Next Year-9.81%
Revenue Next 2Y-1.33%
Revenue Next 3Y4.37%
Revenue Next 5Y11.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALB. In the last year negative earnings were reported.
ALB is valuated quite expensively with a Price/Forward Earnings ratio of 375.95.
71.08% of the companies in the same industry are cheaper than ALB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.70. ALB is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 375.95
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALB indicates a slightly more expensive valuation: ALB is more expensive than 78.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.61
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ALB's earnings are expected to grow with 56.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.61%
EPS Next 3Y56.79%

More info and screens

6

5. Dividend

5.1 Amount

ALB has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.43, ALB pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, ALB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

The dividend of ALB is nicely growing with an annual growth rate of 13.04%!
ALB has been paying a dividend for at least 10 years, so it has a reliable track record.
ALB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.04%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of ALB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-32.53%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

ALBEMARLE CORP

NYSE:ALB (9/17/2025, 8:22:40 PM)

After market: 80.15 -0.01 (-0.01%)

80.16

-0.78 (-0.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners98.79%
Inst Owner Change0.77%
Ins Owners0.36%
Ins Owner Change3.38%
Market Cap9.43B
Analysts68.13
Price Target83.99 (4.78%)
Short Float %10.88%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend2.65
Dividend Growth(5Y)13.04%
DP-32.53%
Div Incr Years30
Div Non Decr Years30
Ex-Date09-12 2025-09-12 (0.405)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.46%
Min EPS beat(2)69.72%
Max EPS beat(2)113.21%
EPS beat(4)2
Avg EPS beat(4)-30.22%
Min EPS beat(4)-249.28%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.6%
EPS beat(12)7
Avg EPS beat(12)-3.87%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)8.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)3.07%
PT rev (3m)1.06%
EPS NQ rev (1m)-11.32%
EPS NQ rev (3m)-137.84%
EPS NY rev (1m)-6.56%
EPS NY rev (3m)-12.71%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.27%
Revenue NY rev (3m)1.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 375.95
P/S 1.89
P/FCF N/A
P/OCF 12.1
P/B 0.92
P/tB 1.13
EV/EBITDA 26.61
EPS(TTM)-2.71
EYN/A
EPS(NY)0.21
Fwd EY0.27%
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)6.62
OCFY8.26%
SpS42.43
BVpS87.02
TBVpS70.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.76%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 7.46
Cap/Depr 146.27%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 182.86%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.47
Altman-Z 1.67
F-Score4
WACC8.36%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y29.4%
EPS Next 2Y44.61%
EPS Next 3Y56.79%
EPS Next 5Y63.36%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%
Revenue Next Year-9.81%
Revenue Next 2Y-1.33%
Revenue Next 3Y4.37%
Revenue Next 5Y11.24%
EBIT growth 1Y79.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.47%
EBIT Next 3Y43.09%
EBIT Next 5Y36.66%
FCF growth 1Y-118.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.5%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%